8-K Announcements
6Material company update
Mar 31, 2026·SEC
Material company update
Mar 20, 2026·SEC
Material company update
Nov 13, 2025·SEC
GoHealth, Inc.(GOCO)Earnings, Financials & Key Ratios
GOCO•NASDAQ•Insurance & Managed Care
$0.30
Price updated Jul 2, 2026
SectorFinancial ServicesIndustryInsurance BrokersSub-IndustryDigital insurance marketplaces and brokers
AboutGoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and IFP and Other—External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.Show more
- Revenue$362M-54.7%
- Combined Ratio142.27%+41.0%
- Net Income-$257M-8681.6%
- Return on Equity-113.5%-17601.4%
- Medical Cost Ratio26.57%+62.5%
- Operating Margin-42.27%-4691.6%
- Net Margin-71.06%-19288.4%
- ROA-20.77%-10497.5%
- Equity / Assets-0.54%-101.7%
GOCO Price & Volume
GoHealth, Inc. (GOCO) stock price & volume — 10-year historical chart
Loading chart...
Severe Revenue Contraction Threatens GoHealth Solvency Profile
Investment Thesis • Updated 2026Q1
VerdictNegative: The company's equity has been nearly entirely eroded
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and Regulatory Headwinds
Key Thesis Takeaways
- GoHealth faces a precarious outlook as its business model undergoes a massive strategic retrenchment, evidenced by quarterly revenue plummeting from $389.1 million in 2024Q4 to just $11.9 million by 2026Q1.
- The company's reliance on speculative ASC 606 contract assets creates a significant disconnect between reported earnings and actual liquidity, leaving shareholders exposed to potential impairments.
- Investors should monitor the firm's ability to stabilize operations, as the current capital structure appears insufficient to support the $1.0 billion liability burden with only $2.1 million in remaining equity.
Verdict Logic
falling to $2.1 million in 2026Q1, which suggests an extremely high risk of insolvency given the persistent operating losses.
GOCO Growth Metrics
GoHealth, Inc. (GOCO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-16.23%
3 Years-16.95%
TTM-81.69%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-15519.63%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-1730.16%
Return on Capital
10 Years-5.64%
5 Years-13.52%
3 Years-7.47%
Last Year-15.32%
GOCO Recent Earnings
GoHealth, Inc. (GOCO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 3/12 qtrs (25%)
Q2 2026Latest
May 18, 2026Metric
Actual
Est
EPS
$2.36+1.7%
$2.40
Rev
$12M-29.5%
$17M
Q2 2026
Mar 31, 2026Metric
Actual
Est
EPS
$1.03+61.7%
$2.69
Rev
$13M-85.7%
$89M
Q4 2025
Nov 13, 2025Metric
Actual
Est
EPS
$0.19+90.8%
$2.06
Rev
$34M-61.4%
$89M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$1.23+52.7%
$2.60
Rev
$94M-18.4%
$115M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 18, 2026 | $2.36vs $2.40+1.7% | $12Mvs $17M-29.5% |
| Q2 2026 | Mar 31, 2026 | $1.03vs $2.69+61.7% | $13Mvs $89M-85.7% |
| Q4 2025 | Nov 13, 2025 | $0.19vs $2.06+90.8% | $34Mvs $89M-61.4% |
| Q3 2025 | Aug 7, 2025 | $1.23vs $2.60+52.7% | $94Mvs $115M-18.4% |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for GoHealth, Inc. (GOCO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.31 | $8.94M | -0.02 | -54.71% | -71.06% | -113.5% | — | |
| $0.81 | $142.51M | 60.78 | 15.5% | 4.45% | 12.16% | — | |
| $1.69 | $52.51M | -4.97 | 4.06% | 6.31% | 3.99% | — | |
| $106.99 | $10.64B | 19.31 | 10.46% | 10.04% | 18.86% | — | |
| $31.09 | $2.86B | -2.56 | 5.04% | -32.84% | -40.92% | — | |
| $38.28 | $8.4B | 75.06 | 59% | -0.56% | -2.48% | — |
Compare GOCO vs Peers
GoHealth, Inc. (GOCO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GOCO SEC Filings & Documents
GoHealth, Inc. (GOCO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when GOCO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GOCO Frequently Asked Questions
GoHealth, Inc. (GOCO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
How fast is GoHealth, Inc. growing?
GoHealth, Inc. (GOCO) saw revenue decline by 54.7% over the past year.
Is GOCO profitable?
GoHealth, Inc. (GOCO) reported a net loss of $289.9M for fiscal year 2025.
Dividend & Returns
What is GOCO's return on equity?
GoHealth, Inc. (GOCO) has a return on equity (ROE) of -113.5%. Negative ROE indicates the company is unprofitable.
Industry Metrics
What is GoHealth, Inc.'s combined ratio?
GoHealth, Inc. (GOCO) has a combined ratio of 142.3%. A ratio above 100% means claims and expenses exceed premiums.